Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kairos Pharma, LTD. | VP of Research and Development | COMMON STOCK | 147K | $234K | $1.59 | Jan 1, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KAPA | Kairos Pharma, LTD. | Jan 1, 2025 | 1 | $0 | 4 | Feb 24, 2025 | VP of Research and Development |
KAPA | Kairos Pharma, LTD. | Nov 25, 2024 | 1 | $318 | 4 | Nov 25, 2024 | VP of Research and Development |
KAPA | Kairos Pharma, LTD. | Sep 16, 2024 | 0 | $0 | 3 | Sep 24, 2024 | VP of Research and Development |